Literature DB >> 28890818

Individualized 4-dimensional computed tomography proton treatment for pancreatic tumors.

Matthew L Knecht1, Ning Wang1, April Vassantachart1, Rachel Mifflin1, Jerry D Slater1, Gary Y Yang1.   

Abstract

BACKGROUND: The goal of this study is to determine whether a phase or reconstruction of a 10-phase 4 dimensional computed tomography (4D CT) scan can be used as the primary planning scan for proton treatment of the pancreas, thus eliminating the need for second a slow CT or free breathing CT.
METHODS: Ten patients with pancreatic adenocarcinoma were simulated with 4D CT and a proton treatment plan generated based upon one of three primary planning scans, the T0 phase, T50 phase or average reconstruction. These plans were then exported to each of the remaining phases of the 4D CT and the dose to 95% of the target (D95) calculated. Plans were deemed adequate if the D95 remained at 99% of the prescribed dose or greater.
RESULTS: For the ten patients in this study anterior abdominal motion was found to range from 2-27 mm (mean 7.50±6.79 mm). For 9 of 10 patients the anterior abdominal motion was ≤8 mm and all three primary planning scans provided adequate target coverage, resulting in minimum D95 coverage per plan of T0_plan 99.7%, T50_plan 99.3% and AVE_plan 99%. However no plan provided adequate target coverage on the single patient with the largest anterior abdominal motion, 27 mm, and cranio-caudal motion, 20 mm, with minimum D95 values of T0_plan 96.3%, T50_plan 68%, and AVE_plan 68%.
CONCLUSIONS: The primary plans tested based up on the T0, T50 and average reconstructions provided adequate D95 coverage throughout the respiratory cycle as long as the anterior abdominal motion was ≤8 mm and can be considered for use as the primary proton planning scan.

Entities:  

Keywords:  4 dimensional computed tomography (4D CT); Proton; stereotactic body radiotherapy

Year:  2017        PMID: 28890818      PMCID: PMC5582042          DOI: 10.21037/jgo.2016.12.10

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  14 in total

1.  Methodologies and tools for proton beam design for lung tumors.

Authors:  M F Moyers; D W Miller; D A Bush; J D Slater
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-04-01       Impact factor: 7.038

2.  Four-dimensional proton treatment planning for lung tumors.

Authors:  Martijn Engelsman; Eike Rietzel; Hanne M Kooy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-04-01       Impact factor: 7.038

Review 3.  Clinical immobilization techniques for proton therapy.

Authors:  Andrew J Wroe; David A Bush; Reinhard W Schulte; Jerry D Slater
Journal:  Technol Cancer Res Treat       Date:  2014-11-11

4.  The effectiveness of a pneumatic compression belt in reducing respiratory motion of abdominal tumors in patients undergoing stereotactic body radiotherapy.

Authors:  D Michael Lovelock; Joan Zatcky; Karyn Goodman; Yoshiya Yamada
Journal:  Technol Cancer Res Treat       Date:  2013-11-04

Review 5.  Physics controversies in proton therapy.

Authors:  Martijn Engelsman; Marco Schwarz; Lei Dong
Journal:  Semin Radiat Oncol       Date:  2013-04       Impact factor: 5.934

6.  Impact of using different four-dimensional computed tomography data sets to design proton treatment plans for distal esophageal cancer.

Authors:  Xiaoning Pan; Xiaodong Zhang; Yupeng Li; Radhe Mohan; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-01       Impact factor: 7.038

7.  Dose escalated liver stereotactic body radiation therapy at the mean respiratory position.

Authors:  Michael Velec; Joanne L Moseley; Laura A Dawson; Kristy K Brock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-08       Impact factor: 7.038

8.  Quantitative assessment of range fluctuations in charged particle lung irradiation.

Authors:  Shinichiro Mori; John Wolfgang; Hsiao-Ming Lu; Robert Schneider; Noah C Choi; George T Y Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-29       Impact factor: 7.038

9.  Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus.

Authors:  Salma K Jabbour; Sameh A Hashem; Walter Bosch; Tae Kyoung Kim; Steven E Finkelstein; Bethany M Anderson; Edgar Ben-Josef; Christopher H Crane; Karyn A Goodman; Michael G Haddock; Joseph M Herman; Theodore S Hong; Lisa A Kachnic; Harvey J Mamon; Jason R Pantarotto; Laura A Dawson
Journal:  Pract Radiat Oncol       Date:  2013-08-07

Review 10.  Range uncertainties in proton therapy and the role of Monte Carlo simulations.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2012-05-09       Impact factor: 3.609

View more
  1 in total

1.  Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesions.

Authors:  Alex R Coffman; Daniel C Sufficool; Joseph I Kang; Chung-Tsen Hsueh; Sasha Swenson; Patrick Q McGee; Gayathri Nagaraj; Baldev Patyal; Mark E Reeves; Jerry D Slater; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2021-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.